Skip to main content

People In The News: Sep 21, 2012

NEW YORK (GenomeWeb News) – The National Center for Advancing Translational Sciences has named Chris Austin to be the first director of the new center, which launched at the beginning of the year and has so far been run by Acting Director Thomas Insel.

Austin began his National Institutes of Health career in 2002, after working as a genomics researcher at Merck, as a senior advisor to the director for translational research at the National Human Genome Research Institute.

At NHGRI, Austin started the Knockout Mouse Project and the Molecular Libraries Roadmap Initiative, and he served as director of the Therapeutics of Rare and Neglected Diseases program and the NIH Chemical Genomics Center, and as scientific director of the NIH Center for Translational Therapeutics.


Cancer biomarker developer Abcodia has appointed Mike Fisher to be director of business development and Steve Pereira as a specialist advisor.

Fisher, who will lead the firm's commercial activities, formerly was business development director at Bio Nano Consulting and a senior advisor to the UK government and the North American UK Trade and Investment Network for the Life Science Industry.

Pereira, who will advise the company on developing biomarkers for early diagnosis and screening of pancreatic cancer, is a consultant gastroenterologist at several hospitals in London and is chairman of the British Society of Gastroenterology's Pancreatic Section.


Chembio Diagnostics has appointed Sharon Klugewicz vice president of quality assurance/quality control and technical operations.

Klugewicz previously was senior vice president of scientific and laboratory services at Pall.


Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.